Early deaths in pediatric acute leukemia: a major challenge in developing countries HA Hafez, RM Soliaman, D Bilal, M Hashem, LM Shalaby Journal of pediatric hematology/oncology 41 (4), 261-266, 2019 | 31 | 2019 |
Incidence, risk factors, and outcome of blood stream infections during the first 100 days post‐pediatric allogeneic and autologous hematopoietic stem cell transplantations A Youssef, H Hafez, Y Madney, M Elanany, O Hassanain, LE Lehmann, ... Pediatric transplantation 24 (1), e13610, 2020 | 28 | 2020 |
Overview and outcome of mucormycosis among children with cancer: report from the Children's Cancer Hospital Egypt Y Madney, R Khedr, N Ahmed, H El‐Mahallawy, A Youssef, H Taha, ... Mycoses 62 (11), 984-989, 2019 | 23 | 2019 |
Temporal trends in childhood cancer survival in Egypt, 2007 to 2017: A large retrospective study of 14 808 children with cancer from the Children's Cancer Hospital Egypt RM Soliman, A Elhaddad, J Oke, W Eweida, I Sidhom, S Ahmed, ... International journal of cancer 148 (7), 1562-1574, 2021 | 22 | 2021 |
Prophylactic levofloxacin in pediatric neutropenic patients during autologous hematopoietic stem cell transplantation HA Hafez, D Yousif, M Abbassi, Y Elborai, A Elhaddad Clinical transplantation 29 (12), 1112-1118, 2015 | 22 | 2015 |
Comparison of toxicity following different conditioning regimens (busulfan/melphalan and carboplatin/etoposide/melphalan) for advanced stage neuroblastoma: Experience of two … Y Elborai, H Hafez, EA Moussa, M Hammad, H Hussein, L Lehmann, ... Pediatric transplantation 20 (2), 284-289, 2016 | 20 | 2016 |
Clinical features and outcome of hepatosplenic fungal infections in children with haematological malignancies Y Madney, L Shalaby, M Elanany, N Adel, E Nasr, K Alsheshtawi, ... Mycoses 63 (1), 30-37, 2020 | 19 | 2020 |
Added predictive value of 18F-FDG PET/CT for pediatric rhabdomyosarcoma E El-Kholy, EEL Nadi, H Hafez, S Ahmed, A Younes, ELK Naglaa, ... Nuclear Medicine Communications 40 (9), 898-904, 2019 | 16 | 2019 |
Impact of CYP1A1, GSTP1 and XRCC1 genes polymorphisms on toxicity and response to chemotherapy in childhood acute lymphoblastic leukemia A Abo-Bakr, G Mossallam, N El Azhary, H Hafez, R Badawy Journal of the Egyptian National Cancer Institute 29 (3), 127-133, 2017 | 13 | 2017 |
Carbapenem-Resistant Enterobacteriaceae (CRE) among Children with Cancer: Predictors of Mortality and Treatment Outcome Y Madney, S Aboubakr, R Khedr, H Hafez, N Ahmed, K Elsheshtawy, ... Antibiotics 12 (2), 405, 2023 | 11 | 2023 |
Patterns, risk factors and outcome predictors of posterior reversible encephalopathy syndrome in pediatric cancer patients HA Hafez, I Ragab, M Sedky, M Shams, A Youssef, A Refaat, E Habib, ... Leukemia & Lymphoma 62 (2), 462-468, 2021 | 9 | 2021 |
Outcomes of allogenic hematopoietic cell transplantation for childhood chronic myeloid leukemia: Single‐center experience HA Hafez, A Abdallah, M Hammad, N Hamdy, D Yassin, S Salem, ... Pediatric Transplantation 24 (4), e13664, 2020 | 9 | 2020 |
Outcome predictors of autologous hematopoietic stem cell transplantation in children with relapsed and refractory Hodgkin lymphoma: Single‐center experience in a lower‐middle … A Abdalla, M Hammad, H Hafez, MS Zaghloul, H Taha, G El‐Hennawy, ... Pediatric Transplantation 23 (6), e13531, 2019 | 9 | 2019 |
Profiling loss of heterozygosity patterns in a cohort of favorable histology nephroblastoma Egyptian patients: what is consistent with the rest of the world M Fawzy, A Bahanassy, A Samir, H Hafez Pediatric Hematology and Oncology 32 (8), 548-556, 2015 | 9 | 2015 |
Providing care for pediatric cancer patients in the COVID‐19 era: Rapid response recommendations from a developing country MM Elzembely, YS Abdelrahman, S Fadel, H Hafez Pediatric Blood & Cancer 67 (8), e28467, 2020 | 8 | 2020 |
MECOM gene overexpression in pediatric patients with acute myeloid leukemia M Elsherif, M Hammad, H Hafez, D Yassin, M Ashraf, N Yasser, ... Acta Oncologica 61 (4), 516-522, 2022 | 7 | 2022 |
“Mucormycosis” the Emerging Global Threat; Overview and Treatment Outcome Among Pediatric Cancer Patients in Egypt Y Madney, R Khedr, H Al-Mahellawy, N Adel, H Taha, I Zaki, A Youssef, ... Blood 130, 4830, 2017 | 7 | 2017 |
Cost-effectiveness of childhood cancer treatment in Egypt: lessons to promote high-value care in a resource-limited setting based on real-world evidence R Soliman, J Oke, I Sidhom, N Bhakta, NS Bolous, N Tarek, S Ahmed, ... EClinicalMedicine 55, 2023 | 6 | 2023 |
RAS pathway mutation patterns in patients with juvenile myelomonocytic leukemia: a developing country single-center experience N Hamdy, H Bokhary, A Elsayed, W Hozayn, S Soliman, S Salem, ... Clinical Lymphoma Myeloma and Leukemia 20 (7), e368-e374, 2020 | 5 | 2020 |
Surgical approaches, anaesthetic management and outcome in pediatric superior mediastinal tumors G Ahmed, MM Hegazy, T Raafat, H Hafez, S Fadel, M Elshafiey Journal of the Egyptian National Cancer Institute 29 (3), 147-153, 2017 | 5 | 2017 |